VMD publishes 2025‑26 Annual Report showing strong regulatory performance

On 1 July 2026, the Veterinary Medicines Directorate (VMD) released its Annual Report and Accounts for 2025‑26, detailing performance in animal health, public health and environmental protection. The report notes that the VMD met many core regulatory targets, achieving 100 % compliance on national applications, inspections, import‑export schemes and product defect handling, up from 96 % in the previous year. Of 38 standards, 22 were fully compliant, 13 between 95‑99 % and only one fell below 85 %. The agency authorised 20 vaccines and issued 130 marketing authorisations for pharmaceuticals, and removed more than 850 illegal listings from online marketplaces. Antimicrobial‑resistance work showed a 57 % decline in antibiotic sales for food‑producing animals since 2014. The report also notes staff growth to 223 and the launch of a surveillance pilot for healthy cats and dogs.

© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/

source

Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.


Posted